These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reconstructing the tumor architecture into organoids. Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370 [TBL] [Abstract][Full Text] [Related]
4. Exploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients. Jeong SR; Kang M Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834057 [TBL] [Abstract][Full Text] [Related]
5. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer. Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y Front Immunol; 2023; 14():1180184. PubMed ID: 37334366 [TBL] [Abstract][Full Text] [Related]
6. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine. Pamarthy S; Sabaawy HE Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953 [TBL] [Abstract][Full Text] [Related]
7. Cancer organoid co-culture model system: Novel approach to guide precision medicine. Yuan J; Li X; Yu S Front Immunol; 2022; 13():1061388. PubMed ID: 36713421 [TBL] [Abstract][Full Text] [Related]
8. Tumor organoid models in precision medicine and investigating cancer-stromal interactions. Xu R; Zhou X; Wang S; Trinkle C Pharmacol Ther; 2021 Feb; 218():107668. PubMed ID: 32853629 [TBL] [Abstract][Full Text] [Related]
9. The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma? Farshbaf A; Lotfi M; Zare R; Mohtasham N Pharmacogenomics J; 2023 May; 23(2-3):37-44. PubMed ID: 36347937 [TBL] [Abstract][Full Text] [Related]
10. Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer. Parikh AS; Yu VX; Flashner S; Okolo OB; Lu C; Henick BS; Momen-Heravi F; Puram SV; Teknos T; Pan Q; Nakagawa H Oral Oncol; 2023 Mar; 138():106330. PubMed ID: 36773387 [TBL] [Abstract][Full Text] [Related]
11. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337 [TBL] [Abstract][Full Text] [Related]
12. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. Li J; Liu J; Xia W; Yang H; Sha W; Chen H Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190 [TBL] [Abstract][Full Text] [Related]
13. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791 [TBL] [Abstract][Full Text] [Related]
14. Organoids: An intermediate modeling platform in precision oncology. Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804 [TBL] [Abstract][Full Text] [Related]
15. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends. Song SL; Li B; Carvalho MR; Wang HJ; Mao DL; Wei JT; Chen W; Weng ZH; Chen YC; Deng CX; Reis RL; Oliveira JM; He YL; Yan LP; Zhang CH Pharmacol Ther; 2022 Nov; 239():108276. PubMed ID: 36055421 [TBL] [Abstract][Full Text] [Related]
16. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold. Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901 [TBL] [Abstract][Full Text] [Related]
17. Organoids: approaches and utility in cancer research. Zhou B; Feng Z; Xu J; Xie J Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679 [TBL] [Abstract][Full Text] [Related]
18. Converging bioprinting and organoids to better recapitulate the tumor microenvironment. Wang X; Luo Y; Ma Y; Wang P; Yao R Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145 [TBL] [Abstract][Full Text] [Related]
19. Immune organoids: from tumor modeling to precision oncology. Dao V; Yuki K; Lo YH; Nakano M; Kuo CJ Trends Cancer; 2022 Oct; 8(10):870-880. PubMed ID: 35773148 [TBL] [Abstract][Full Text] [Related]
20. Tumor organoids: applications in cancer modeling and potentials in precision medicine. Xu H; Jiao D; Liu A; Wu K J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]